EP1268849A2 - Reagents and methods for detecting a reduced cofactor - Google Patents

Reagents and methods for detecting a reduced cofactor

Info

Publication number
EP1268849A2
EP1268849A2 EP01916527A EP01916527A EP1268849A2 EP 1268849 A2 EP1268849 A2 EP 1268849A2 EP 01916527 A EP01916527 A EP 01916527A EP 01916527 A EP01916527 A EP 01916527A EP 1268849 A2 EP1268849 A2 EP 1268849A2
Authority
EP
European Patent Office
Prior art keywords
signal producing
electron transfer
reagent
transfer agent
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01916527A
Other languages
German (de)
French (fr)
Inventor
Tianmei Ouyang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Publication of EP1268849A2 publication Critical patent/EP1268849A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90212—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)

Definitions

  • the field of this invention is analyte detection, particularly reagent systems for use in analyte detection
  • Analyte detection in physiological fluids is of ever increasing importance to today's society
  • Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc , where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions
  • Analytes of interest include alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc
  • a variety of analyte detection protocols and devices for both clinical and home use have been developed
  • Many of the protocols and devices that have been developed to date employ a signal producing system to identify the presence of the analyte of interest in a physiological sample, such as blood
  • One type of signal producing system that finds use in the detection of a variety of different analytes is one in which a dehydrogenase oxidize
  • U S Patents of interest include 4,629,697, 5, 126,247 and 5,902,731 See also Raap et al , Histochem J (1983) 15 881-893 SUMMARY OF THE INVENTION
  • Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample are provided
  • the subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e g a phenazine compound and a diaphorase
  • the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e g an analyte dehydrogenase
  • the subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample
  • FIGURES Fig 1 provides a graphical representation of the observed rate of reaction in a test strip according to the subject invention vs the theoretical expected rate of reaction for a test strip that includes both PMS and a diaphorase, clearly demonstrating that the use of both a non-proteinaceous and proteinaceous electron transfer agent, e g PMS and a diaphorase, provides for an unexpected increase in the rate of reaction
  • the subject signal producing systems are characte ⁇ zed by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e g a phenazine compound and a diaphorase
  • the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e g an analyte dehydrogenase
  • the subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e g blood or a fraction thereof
  • the subject invention provides a signal producing system that is capable of detecting the presence of a reduced enzyme cofactor in a sample
  • signal producing system is meant a collection of two or more compounds or molecules which are capable of acting in concert, when combined, to produce a detectable signal that is indicative of the presence of, and often amount of, a particular analyte in a given sample
  • the term signal producing system is used broadly to encompass both a mixture of all of the reagent constituents of the signal producing system as well as a system in which one or more of the reagent constituents are separated from the remainder of the reagent constituents, e g as is present m a kit
  • a feature of the subject signal producing systems is the presence of two distinct electron transfer agents
  • electron transfer agent is meant a compound or molecule that can transfer an electron, m the form of a hydride ion, from a reduced enzyme cofactor to a redox indicator
  • the first of the distinct electron transfer agents is a low molecular weight molecule
  • the second electron transfer agent is a high molecular weight molecule
  • low molecular weight means a molecular weight that does not exceed about 2000 daltons, usually about 1000 daltons and m many embodiments about 500 daltons
  • High molecular weight means a molecular weight of at least about 5000 daltons and in many embodiments 10,000 or 20,000 daltons or higher
  • the molecular weight of the high molecular weight electron transfer agent often will not exceed about 100,000 daltons
  • the low molecular weight electron transfer agent is a non-proteinaceous compound while the high molecular weight electron transfer agent is a proteinaceous compound
  • proteinaceous is meant a
  • a variety of low molecular weight non-proteinaceous electron transfer agents are of interest These agents include flavins such as riboflavin (RBF), alloxazine (ALL) and lumichrome (LC), phenazines such as phenazine, phenazine methosulfate (PMS), phenazine ethosulfate, methoxyphenazine methosulfate and safranine, methyl- 1, 4-naphthol (menadione), phenothiazines such as PT and its radical cation, PT+, thionin (TH), azure A (AA), azure B (AB), azure C (AC), methylene blue (MB), methylene green (MG) and toluidine blue O (TOL), phenoxazines such as phenoxazine (POA), basic blue 3 (BB3), and brilliant cresyl blue ALD (BCBA), benzo- -phenazo
  • the high molecular weight proteinaceous electron transfer agent is an enzyme that is capable of oxidizing a reduced cofactor, e g NAD(P)H, and concomitantly reducing a redox indicator.
  • this electron transfer enzyme is a diaphorase, such as lipoic dehydrogenase, ferredoxin-NADP reductase, lipoamide dehydrogenase, NADPH dehydrogenase, etc
  • diaphorases are available and may be employed, where representative commercially available diaphorases that may be present in the subject signal producing systems include bacillus diaphorase, clostridium diaphorase, vibrio diaphorase, porcine diaphorase, and the like
  • the ratio of the first to the second electron transfer agent is chosen to provide for an accelerated reaction rate as compared to a control, e g a comparable signal producing system with a single electron transfer agent, e g only PMS or a diaphorase
  • the ratio of the first to the second electron transfer agent in the subject systems ranges from about 0 001 to 10, usually from about 0 01 to 1 0 and more usually from about 0 05 to 0 5 (nmole/U), respectively
  • the subject signal producing systems also include a redox indicator
  • redox indicator is meant a compound that is capable of being reduced by the electron transfer agents to produce a detectable, e g chromogemc, product Where the redox indicator produces a chromogenic product, i.e.
  • the redox indicator is a chromogen
  • suitable chromogens are any compound capable of changing color upon reduction by one or more electrons, where suitable chromogens are generally ones that accept electrons from the electron transfer agents, described above.
  • a variety of different redox indicator compounds are of interest.
  • Compounds of interest include: oxazines, thiazines, and tetrazolium salts.
  • tetrazolium salts which are capable of accepting the captured hydride from the electron transfer agents to form a colored formazan product.
  • these salts have the advantageous feature of being faint yellow in the oxidized form, but turn bright visible colors upon electron reduction and conversion to formazan dyes.
  • Tetrazolium compounds or salts that are of particular interest include: 2-(2' benzothiazolyl)-5-styryl-3- (4'-phthalhydrazidyl) tetrazolium (BSPT); 2-benzothiazolyl-(2)-3,5-diphenyl tetrazolium (BTDP); 2,3-di(4-nitrophenyl) tetrazolium (DNP); 2,5-diphenyl-3-(4-styrylphenyl) tetrazolium (DPSP); distyryl nitroblue tetrazolium (DS-NBT); 3,3'-[3,3'-dimethoxy-(l,l - biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5- phenyl(-2H tetrazolium (NBT); 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium (MTT);
  • WST-5 is preferred in many embodiments because it readily dissolves in an aqueous medium, which is most compatible with biological samples. Furthermore, the resulting formazan compound exhibits strong spectral absorption at the purple-blue region, thus reducing the need for correcting the background signal from hemoglobin.
  • Other useful tetrazolium salts are disclosed in U.S. Pat. Nos.
  • the above described signal producing systems are capable of detecting the presence of a reduced enzyme cofactor in a sample, particularly an aqueous sample and more particularly a physiological sample, e.g. whole blood or a fraction or derivative thereof.
  • a variety of different reduced enzyme cofactors may be detected using the subject signal producing systems, where representative reduced enzyme cofactors include the reduced forms of the following cofactors beta-nicotinamide ademne dinucleotide (beta-NAD), beta- nicotinamide ademne dinucleotide phosphate (beta-NADP), thiomcotinamide ademne dinucleotide, thiomcotinamide ademne dinucleotide phosphate, mcotinamide 1,N6- ethenoademne dmucleotide, mcotinamide l,N6-ethenoademne dinucleotide phosphate, and pyrrolo-quinohne quinone (PQQ)
  • the subject signal producing systems are particularly suited for use in the detection of NADH or NAD(P)H
  • the reduced enzyme cofactor is one that is produced following the oxidation of an analyte of interest in a sample
  • the subject signal producing systems also include the enzyme cofactor and an analyte oxidizing enzyme that is capable of oxidizing the analyte of interest and concomitantly reducing the enzyme cofactor
  • Enzyme cofactors of interest include those desc ⁇ bed above, I e beta-nicotinamide ademne dinucleotide (beta-NAD), beta-nicotinamide ademne dinucleotide phosphate (beta-NADP), thiomcotinamide ademne dmucleotide, thiomcotinamide ademne dinucleotide phosphate, mcotinamide 1 ,N6-ethenoaden ⁇ ne dinucleotide, mcotinamide l,N6-ethen
  • reagent compositions for use in detecting at least a reduced enzyme cofactor, and in many embodiments and analyte, in a sample
  • the reagent compositions may be fluid, e g aqueous, or dry compositions, where in many embodiments the reagent compositions are dry compositions
  • the subject reagent compositions are ones that include the first and second electron transfer agent and the redox indicator, where these components are described above
  • Such reagent compositions are suitable for use in the detection of reduced enzyme cofactors, e g
  • the reagent compositions further include an enzyme cofactor and an analyte oxidizing enzyme, where these components are described above
  • the subject invention provides dry strips for assaying for a particular analyte in whole blood, e g in beta-hydroxybutyrate, glucose, etc
  • the reagent test strip includes a solid support and a dry reagent composition present thereon, where the dry reagent composition is made up of all of the reagent compounds necessary to produce a detectable signal in the presence of the analyte of interest
  • the dry reagent composition present on the subject test strip is one that includes the following members an analyte oxidizing enzyme, an enzyme cofactor, first and second electron transfer agents and a redox indicator, where each of these constituent members are described in greater detail supra.
  • the subject test strips include a membrane test pad that is affixed to a solid support
  • the support may be a plastic - e g , polystyrene, nylon, or polyester - or metallic sheet or any other suitable material known in the art
  • the test pad preferably comprises a bibulous, such as filter paper or polymer membrane Associated with the test pad, e g coated onto the test pad, incorporated into the test pad, etc , is the reagent composition
  • the strip may also be configured in more complex arrangements, e g where the test pad is present between the support and a surface layer, where one or more reagents employed in sample processing may be present on the surface layer
  • flow paths or channels may be present on the test strip, as is known in the art Of interest in many embodiments are the test strip configurations disclosed in U S Patent No 5,902,731. the disclosure of which is herein incorporated by reference
  • the subject test strips may be fabricated employing any convenient protocol
  • One convenient protocol is to contact at least the test pad portion of the strip with an aqueous composition that includes all of the members of the reagent composition that is to be associated with the test pad in the final reagent test st ⁇ p
  • the test pad may be immersed m the aqueous composition, maintained therein for a sufficient pe ⁇ od of time and then d ⁇ ed, whereby the test pad of the reagent test st ⁇ p which has associated therewith the reagent composition is produced
  • the aqueous composition will include the va ⁇ ous members of the reagent composition to be associated with the test pad of the reagent test st ⁇ p, where the va ⁇ ous members are present in amounts sufficient to provide for the desired amounts in the reagent composition that is produced on the test pad
  • the concentration of non-proteinaceous electron transfer agent present in this aqueous composition typically ranges from about 1 ⁇ M to 1000 ⁇ M, usually from about 10 ⁇ M to
  • the analyte oxidizing agent enzyme ranges in concentration from about 100 U to 2000 U, and usually from about 200 U to 1000 U when present
  • Other components that may be present in this aqueous composition employed to prepare the reagent test st ⁇ p include sodium chlo ⁇ de, magnesium chlo ⁇ de, T ⁇ s, PSSA, Tetromc 1307, Crotein-SPA, sucrose, oxamic acid, sodium salt, and the like See the expe ⁇ mental section, infra, for a more detailed desc ⁇ ption of a representative method for prepa ⁇ ng the subject reagent test st ⁇ ps
  • the above desc ⁇ bed signal producing systems, reagent compositions and test st ⁇ ps find use in methods of detecting the presence of, and often the amount of, an analyte in a sample
  • a va ⁇ ety of different analytes may be detected using the subject methods, where representative analytes include those desc ⁇ bed above, e g alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc
  • the subject methods may be used to determine the presence, and often concentration, of an analyte in a variety of different physiological samples, such as u ⁇ ne, tears, saliva, and the like, they are particularly suited for use in determining the concentration of an analyte in blood or blood fractions, e g blood de ⁇ ved samples, and more particularly in whole blood
  • An important feature of the subject methods is that use of the subject signal producing systems that include
  • the sample and the signal producing system are combined into a reaction mixture, the reaction is allowed to proceed for a sufficient period to time to generate a signal indicative of the presence of (and often amount of) analyte in the sample, and the resultant signal is detected and related to the presence of (and often amount of) analyte in the sample.
  • the reaction mixture may be produced in any convenient environment, such as a cuvette or other fluid containment means.
  • the above steps take place on a reagent test strip as described supra
  • the subject methods are now discussed further in terms of methods in which a reagent test strip is employed
  • the first step is to apply a quantity of the physiological sample to the test strip, where the test strip is described supra
  • the amount of physiological sample, e g blood, that is applied to the test strip may vary, but generally ranges from about 2 ⁇ L to 40 ⁇ L, usually from about 5 ⁇ L to 20 ⁇ L
  • the blood sample size that is applied to the test strip may be relatively small, ranging in size from about 2 ⁇ L to 40 ⁇ L, usually from about 5 ⁇ L to 20 ⁇ L
  • blood samples of a variety of different hematocrits may be assayed with the subject methods, where the hematocrit may range from about 20% to 65%, usually from about 25% to 60%
  • the sample is allowed to react with the members of the signal producing system to produce a detectable product that is present in an amount proportional to the initial amount of the analyte of interest present in the sample
  • kits for use in practicing the subject methods at least include a signal producing system as described above, where the signal producing system components may be combined into a single reagent composition or separated, e g present in separate containers
  • the signal producing system will be present in the kits in the form of a reagent test strip, as described supra
  • the subject kits may further include a means for obtaining a physiological sample
  • the subject kits may further include a means for obtaining a blood sample, such as a lance for sticking a finger, a lance actuation means, and the like
  • the subject kits may include a control solution or standard, e g an analyte control solution that contains a standardized concentration of analyte
  • the kits also include an automated instrument, as described above, for detecting the amount of product produced on the st ⁇ p following sample application and relating the detected product to the amount of analyte in the sample
  • the kits also include an automated instrument, as described above, for detecting the amount of product produced on the st ⁇ p
  • Table 3 provides a comparison of the observed rate and the expected or theoretical rate for the above described assays.
  • Fig 1 provides a graph of the observed rate vs the theoretical rate
  • the reaction rate of the signal producing system of the test strip is accelerated by the presence of both PMS and Diaphorase, where the magnitude of the observed acceleration is unexpectedly greater than the predicted amount of acceleration based on the sum of the reaction rates of systems having PMS or Diaphorase individually
  • the subject invention provides for a significant and unexpected enhancement in the rate of reaction observed in an analyte detection protocol based on the oxidation of an analyte and the concomitant reduction of a redox indicator
  • the subject invention provides for a more economical manner of analyte detection, as compared to certain prior art methods, e g ones that rely solely on diaphorase as the electron transfer agent. As such, the subject invention represents a significant contribution to the art.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazine compound and a diaphorase. In many preferred embodiments, the subject systems and kits further include at least one of and often both of an enzyme cofactor and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e.g. blood or a fraction thereof.

Description

REAGENT SYSTEMS FOR DETECTING THE PRESENCE OF A REDUCED COFACTOR TN A SAMPLE AND METHODS FOR USING THE SAME
INTRODUCTION Field of the Invention
The field of this invention is analyte detection, particularly reagent systems for use in analyte detection
Background of the Invention Analyte detection in physiological fluids, e g blood or blood derived products, is of ever increasing importance to today's society Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc , where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions Analytes of interest include alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc In response to this growing importance of analyte detection, a variety of analyte detection protocols and devices for both clinical and home use have been developed Many of the protocols and devices that have been developed to date employ a signal producing system to identify the presence of the analyte of interest in a physiological sample, such as blood One type of signal producing system that finds use in the detection of a variety of different analytes is one in which a dehydrogenase oxidizes the analyte of interest and concomitantly reduces an enzyme cofactor, such as NAD(P)+ The reduced form of the cofactor, e g NAD(P)H, is then detected through subsequent reaction with a cofactor oxidizing agent, e g phenazine methosulfate or a diaphorase, that transfers an electron to a redox indicator, such as a tetrazolium salt, to produce a detectable product
While a variety of such signal producing systems have been developed to date for use in the detection of a wide variety of different analytes, there continues to be a need for the further development of such systems For example, a signal producing system which provided for an enhanced reaction rate and a lower cost would be of great interest Relevant Literature
U S Patents of interest include 4,629,697, 5, 126,247 and 5,902,731 See also Raap et al , Histochem J (1983) 15 881-893 SUMMARY OF THE INVENTION Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e g a phenazine compound and a diaphorase In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e g an analyte dehydrogenase The subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e g blood or a fraction thereof
BRIEF DESCRIPTION OF THE FIGURES Fig 1 provides a graphical representation of the observed rate of reaction in a test strip according to the subject invention vs the theoretical expected rate of reaction for a test strip that includes both PMS and a diaphorase, clearly demonstrating that the use of both a non-proteinaceous and proteinaceous electron transfer agent, e g PMS and a diaphorase, provides for an unexpected increase in the rate of reaction
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided The subject signal producing systems are characteπzed by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e g a phenazine compound and a diaphorase In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e g an analyte dehydrogenase The subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e g blood or a fraction thereof
Before the subject invention is described further, it is to be understood that the invention is not limited to the particular embodiments of the invention described below, as vaπations of the particular embodiments may be made and still fall within the scope of the appended claims It is also to be understood that the terminology employed is for the purpose of descπbing particular embodiments, and is not intended to be limiting Instead, the scope of the present invention will be established by the appended claims
In this specification and the appended claims, singular references include the plural, unless the context clearly dictates otherwise Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs
SIGNAL PRODUCING SYSTEMS
As summarized above, the subject invention provides a signal producing system that is capable of detecting the presence of a reduced enzyme cofactor in a sample By signal producing system is meant a collection of two or more compounds or molecules which are capable of acting in concert, when combined, to produce a detectable signal that is indicative of the presence of, and often amount of, a particular analyte in a given sample The term signal producing system is used broadly to encompass both a mixture of all of the reagent constituents of the signal producing system as well as a system in which one or more of the reagent constituents are separated from the remainder of the reagent constituents, e g as is present m a kit
A feature of the subject signal producing systems is the presence of two distinct electron transfer agents By electron transfer agent is meant a compound or molecule that can transfer an electron, m the form of a hydride ion, from a reduced enzyme cofactor to a redox indicator In the subject signal producing systems, the first of the distinct electron transfer agents is a low molecular weight molecule, while the second electron transfer agent is a high molecular weight molecule In this specification, low molecular weight means a molecular weight that does not exceed about 2000 daltons, usually about 1000 daltons and m many embodiments about 500 daltons High molecular weight means a molecular weight of at least about 5000 daltons and in many embodiments 10,000 or 20,000 daltons or higher The molecular weight of the high molecular weight electron transfer agent often will not exceed about 100,000 daltons In many embodiments, the low molecular weight electron transfer agent is a non-proteinaceous compound while the high molecular weight electron transfer agent is a proteinaceous compound By proteinaceous is meant a polypeptide or polymeric mimetic thereof
A variety of low molecular weight non-proteinaceous electron transfer agents are of interest These agents include flavins such as riboflavin (RBF), alloxazine (ALL) and lumichrome (LC), phenazines such as phenazine, phenazine methosulfate (PMS), phenazine ethosulfate, methoxyphenazine methosulfate and safranine, methyl- 1, 4-naphthol (menadione), phenothiazines such as PT and its radical cation, PT+, thionin (TH), azure A (AA), azure B (AB), azure C (AC), methylene blue (MB), methylene green (MG) and toluidine blue O (TOL), phenoxazines such as phenoxazine (POA), basic blue 3 (BB3), and brilliant cresyl blue ALD (BCBA), benzo- -phenazoxonium chloride (Medola's blue), Indophenols such as 2,6-dichlorophenol indophenol (DCIP), and Indamines such as Bindschedler's green and phenylene blue, and the like.: Of particular interest in many embodiments are phenazine compounds, e g PMS, phenazine ethosulfate, methoxyphenazine methosulfate and safranine, where PMS is the low molecular weight, non-proteinaceous electron transfer agent in many embodiments
In many embodiments, the high molecular weight proteinaceous electron transfer agent is an enzyme that is capable of oxidizing a reduced cofactor, e g NAD(P)H, and concomitantly reducing a redox indicator. In many embodiments, this electron transfer enzyme is a diaphorase, such as lipoic dehydrogenase, ferredoxin-NADP reductase, lipoamide dehydrogenase, NADPH dehydrogenase, etc A variety of diaphorases are available and may be employed, where representative commercially available diaphorases that may be present in the subject signal producing systems include bacillus diaphorase, clostridium diaphorase, vibrio diaphorase, porcine diaphorase, and the like
In the subject signal producing systems, the ratio of the first to the second electron transfer agent is chosen to provide for an accelerated reaction rate as compared to a control, e g a comparable signal producing system with a single electron transfer agent, e g only PMS or a diaphorase Typically, the ratio of the first to the second electron transfer agent in the subject systems ranges from about 0 001 to 10, usually from about 0 01 to 1 0 and more usually from about 0 05 to 0 5 (nmole/U), respectively In addition to the above described first and second electron transfer agents, the subject signal producing systems also include a redox indicator By redox indicator is meant a compound that is capable of being reduced by the electron transfer agents to produce a detectable, e g chromogemc, product Where the redox indicator produces a chromogenic product, i.e. the redox indicator is a chromogen, suitable chromogens are any compound capable of changing color upon reduction by one or more electrons, where suitable chromogens are generally ones that accept electrons from the electron transfer agents, described above. A variety of different redox indicator compounds are of interest. Compounds of interest include: oxazines, thiazines, and tetrazolium salts. Of particular interest in many embodiments are tetrazolium salts which are capable of accepting the captured hydride from the electron transfer agents to form a colored formazan product. In many embodiments, these salts have the advantageous feature of being faint yellow in the oxidized form, but turn bright visible colors upon electron reduction and conversion to formazan dyes. Tetrazolium compounds or salts that are of particular interest include: 2-(2' benzothiazolyl)-5-styryl-3- (4'-phthalhydrazidyl) tetrazolium (BSPT); 2-benzothiazolyl-(2)-3,5-diphenyl tetrazolium (BTDP); 2,3-di(4-nitrophenyl) tetrazolium (DNP); 2,5-diphenyl-3-(4-styrylphenyl) tetrazolium (DPSP); distyryl nitroblue tetrazolium (DS-NBT); 3,3'-[3,3'-dimethoxy-(l,l - biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5- phenyl(-2H tetrazolium (NBT); 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium (MTT); 2-phenyl-3-(4-carboxyphenyl)-5- methyl tetrazolium (PCPM); tetrazolium blue (TB); thiocarbamyl nitroblue tetrazolium (TCNBT); tetranitroblue tetrazolium (TNBT); tetrazolium violet (TV); 2- benzothiazothiazolyl-3-(4-carboxy-2-methoxyphenyl)-5-[4-(2-sulfoethylcarbamoyl)phenyl]- 2H-tetrazolium (WST-4); 2,2'-dibenzothiazolyl-5,5'-bis[4-di(2- sulfoethyl)carbamoylphenyl]-3,3 '-(3,3 '-dimethoxy- 4,4'-biphenylene)ditetrazolium, disodium salt (WST-5); 2-(p-nitrophenyl)-3-(p-iodophenyl)-5-phenyltetrazolium chloride (INT); and the like. WST-5 is preferred in many embodiments because it readily dissolves in an aqueous medium, which is most compatible with biological samples. Furthermore, the resulting formazan compound exhibits strong spectral absorption at the purple-blue region, thus reducing the need for correcting the background signal from hemoglobin. Other useful tetrazolium salts are disclosed in U.S. Pat. Nos. 4,490,465; 4,491,631; 4,598,042; 4,351,899; 4,271,265; 4,247,633; 4,223,090; 4,215,917; 4,142,938; 4,024,021; 3,867,259; 3,867,257; 3,791,931; and 4,254,222; the disclosures of which are herein incorporated by reference. The above described signal producing systems are capable of detecting the presence of a reduced enzyme cofactor in a sample, particularly an aqueous sample and more particularly a physiological sample, e.g. whole blood or a fraction or derivative thereof. A variety of different reduced enzyme cofactors may be detected using the subject signal producing systems, where representative reduced enzyme cofactors include the reduced forms of the following cofactors beta-nicotinamide ademne dinucleotide (beta-NAD), beta- nicotinamide ademne dinucleotide phosphate (beta-NADP), thiomcotinamide ademne dinucleotide, thiomcotinamide ademne dinucleotide phosphate, mcotinamide 1,N6- ethenoademne dmucleotide, mcotinamide l,N6-ethenoademne dinucleotide phosphate, and pyrrolo-quinohne quinone (PQQ) The subject signal producing systems are particularly suited for use in the detection of NADH or NAD(P)H
In many applications in which the subject signal producing systems find use, the reduced enzyme cofactor is one that is produced following the oxidation of an analyte of interest in a sample In many embodiments, therefore, the subject signal producing systems also include the enzyme cofactor and an analyte oxidizing enzyme that is capable of oxidizing the analyte of interest and concomitantly reducing the enzyme cofactor Enzyme cofactors of interest include those descπbed above, I e beta-nicotinamide ademne dinucleotide (beta-NAD), beta-nicotinamide ademne dinucleotide phosphate (beta-NADP), thiomcotinamide ademne dmucleotide, thiomcotinamide ademne dinucleotide phosphate, mcotinamide 1 ,N6-ethenoadenιne dinucleotide, mcotinamide l,N6-ethenoadenιne dinucleotide phosphate, and pyrrolo-qumolme quinone (PQQ) Enzyme cofactors of particular interest that may be included in the subject signal producing systems include NADH or NAD(P)H The analyte oxidizing enzyme present in the signal producing system necessaπly depends on the nature of the analyte to be detected with the system Representative analyte oxidizing enzymes of interest include alcohol dehydrogenase for alcohol, formaldehyde dehydrogenase for formaldehyde, glucose dehydrogenase for glucose, glucose-6-phosphate dehydrogenase for glucose-6-phosphate, glutamate dehydrogenase for glutamic acid, glycerol dehydrogenase for glycerol, beta-hydroxybutyrate dehydrogenase for beta- hydroxybutyrate, hydroxysteroid dehydrogenase for steroid, L-lactate dehydrogenase for L- lactate, leucine dehydrogenase for leucine, malate dehydrogenase for malic acid, and pyruvate dehydrogenase for pyruvic acid As can be seen from the above representative list, the analyte oxidizing enzyme is typically a dehydrogenase
REAGENT COMPOSITIONS
Also provided by the subject invention are reagent compositions for use in detecting at least a reduced enzyme cofactor, and in many embodiments and analyte, in a sample The reagent compositions may be fluid, e g aqueous, or dry compositions, where in many embodiments the reagent compositions are dry compositions At a minimum, the subject reagent compositions are ones that include the first and second electron transfer agent and the redox indicator, where these components are described above Such reagent compositions are suitable for use in the detection of reduced enzyme cofactors, e g
NAD(P)H, in a sample In many embodiments, however, the reagent compositions further include an enzyme cofactor and an analyte oxidizing enzyme, where these components are described above
REAGENT TEST STRIPS
Also provided by the subject invention are reagent test strips for use in detecting the presence of an analyte in a sample In particular, the invention provides dry strips for assaying for a particular analyte in whole blood, e g in beta-hydroxybutyrate, glucose, etc In the broadest sense, the reagent test strip includes a solid support and a dry reagent composition present thereon, where the dry reagent composition is made up of all of the reagent compounds necessary to produce a detectable signal in the presence of the analyte of interest In most embodiments of the subject invention, the dry reagent composition present on the subject test strip is one that includes the following members an analyte oxidizing enzyme, an enzyme cofactor, first and second electron transfer agents and a redox indicator, where each of these constituent members are described in greater detail supra.
In many embodiments, the subject test strips include a membrane test pad that is affixed to a solid support The support may be a plastic - e g , polystyrene, nylon, or polyester - or metallic sheet or any other suitable material known in the art In many embodiments, the test pad preferably comprises a bibulous, such as filter paper or polymer membrane Associated with the test pad, e g coated onto the test pad, incorporated into the test pad, etc , is the reagent composition The strip may also be configured in more complex arrangements, e g where the test pad is present between the support and a surface layer, where one or more reagents employed in sample processing may be present on the surface layer In addition, flow paths or channels may be present on the test strip, as is known in the art Of interest in many embodiments are the test strip configurations disclosed in U S Patent No 5,902,731. the disclosure of which is herein incorporated by reference
The subject test strips may be fabricated employing any convenient protocol One convenient protocol is to contact at least the test pad portion of the strip with an aqueous composition that includes all of the members of the reagent composition that is to be associated with the test pad in the final reagent test stπp Convemently, the test pad may be immersed m the aqueous composition, maintained therein for a sufficient peπod of time and then dπed, whereby the test pad of the reagent test stπp which has associated therewith the reagent composition is produced As stated above, the aqueous composition will include the vaπous members of the reagent composition to be associated with the test pad of the reagent test stπp, where the vaπous members are present in amounts sufficient to provide for the desired amounts in the reagent composition that is produced on the test pad As such, the concentration of non-proteinaceous electron transfer agent present in this aqueous composition typically ranges from about 1 μM to 1000 μM, usually from about 10 μM to 500 μM, while the concentration of proteinaceous electron transfer agent in the aqueous composition ranges from about 50U to 3000 U, usually from about 100 U to 1000 U The concentration of redox reagent present in the aqueous composition ranges from about 3 mM to 36 mM, usually from about 6 mM to 24mM When present, the enzyme cofactor ranges in concentration from about 1 5 mM to 28 mM, usually from about 3 5mM to 14 mM
Similarly, the analyte oxidizing agent enzyme ranges in concentration from about 100 U to 2000 U, and usually from about 200 U to 1000 U when present Other components that may be present in this aqueous composition employed to prepare the reagent test stπp include sodium chloπde, magnesium chloπde, Tπs, PSSA, Tetromc 1307, Crotein-SPA, sucrose, oxamic acid, sodium salt, and the like See the expeπmental section, infra, for a more detailed descπption of a representative method for prepaπng the subject reagent test stπps
METHODS OF ANALYTE DETECTION
The above descπbed signal producing systems, reagent compositions and test stπps find use in methods of detecting the presence of, and often the amount of, an analyte in a sample A vaπety of different analytes may be detected using the subject methods, where representative analytes include those descπbed above, e g alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc While in pπnciple, the subject methods may be used to determine the presence, and often concentration, of an analyte in a variety of different physiological samples, such as uπne, tears, saliva, and the like, they are particularly suited for use in determining the concentration of an analyte in blood or blood fractions, e g blood deπved samples, and more particularly in whole blood An important feature of the subject methods is that use of the subject signal producing systems that include both first and second electron transfer agents provides for an accelerated reaction time as compared to a control system, e g a system that includes a single electron transfer agent Generally, the reaction rate is accelerated or enhanced by a factor of 1 to 3 depending on the ratio of PMS and diaphorase Furthermore, the reaction rate is greater than the theoretical or predicted rate which would be expected based on the summation of the rates provided by the individual electron transfer agents by a factor of 1 to3 Where the reaction rate is measured in terms of K/S per sec (see the experimental section infra) the K/S per sec for a reaction in which the subject signal producing systems are employed typically ranges from about 0 01 to 10, usually from about 0 05 to 5 and more usually from about 0 1 to 2
In the subject methods, the sample and the signal producing system are combined into a reaction mixture, the reaction is allowed to proceed for a sufficient period to time to generate a signal indicative of the presence of (and often amount of) analyte in the sample, and the resultant signal is detected and related to the presence of (and often amount of) analyte in the sample. In the broadest sense, the reaction mixture may be produced in any convenient environment, such as a cuvette or other fluid containment means. However, in many embodiments, the above steps take place on a reagent test strip as described supra As such, the subject methods are now discussed further in terms of methods in which a reagent test strip is employed
In practicing the subject methods, the first step is to apply a quantity of the physiological sample to the test strip, where the test strip is described supra The amount of physiological sample, e g blood, that is applied to the test strip may vary, but generally ranges from about 2μL to 40μL, usually from about 5 μL to 20μL Because of the nature of the subject test strip, the blood sample size that is applied to the test strip may be relatively small, ranging in size from about 2μL to 40μL, usually from about 5μL to 20μL Where blood is the physiological sample, blood samples of a variety of different hematocrits may be assayed with the subject methods, where the hematocrit may range from about 20% to 65%, usually from about 25% to 60% Following application of the sample to the test strip, the sample is allowed to react with the members of the signal producing system to produce a detectable product that is present in an amount proportional to the initial amount of the analyte of interest present in the sample The amount of detectable product, i e signal produced by the signal producing system, is then determined and related to the amount of analyte in the initial sample In certain embodiments, automated instruments that perform the above mentioned detection and relation steps are employed The above described reaction, detection and relating steps, as well as instruments for performing the same, are further described in U S Patent Nos 4,734,360, 4,900,666, 4,935,346, 5,059,394, 5,304,468, 5,306,623, 5,418,142, 5,426,032, 5,515,170, 5,526,120, 5,563,042, 5,620,863, 5,753,429, 5,573,452, 5,780,304, 5,789,255, 5,843,691, 5,846,486, 5,902,731, 5,968,836 and 5,972,294, the disclosures of which are herein incorporated by reference In the relation step, the derived analyte concentration takes into account the constant contribution of competing reactions to the observed signal, e g by calibrating the instrument accordingly
KITS
Also provided by the subject invention are kits for use in practicing the subject methods The kits of the subject invention at least include a signal producing system as described above, where the signal producing system components may be combined into a single reagent composition or separated, e g present in separate containers In certain embodiments, the signal producing system will be present in the kits in the form of a reagent test strip, as described supra The subject kits may further include a means for obtaining a physiological sample For example, where the physiological sample is blood, the subject kits may further include a means for obtaining a blood sample, such as a lance for sticking a finger, a lance actuation means, and the like In addition, the subject kits may include a control solution or standard, e g an analyte control solution that contains a standardized concentration of analyte In certain embodiments, the kits also include an automated instrument, as described above, for detecting the amount of product produced on the stπp following sample application and relating the detected product to the amount of analyte in the sample Finally, the kits include instructions for using the subject kit components in the determination of an analyte concentration in a physiological sample These instructions may be present on one or more of the packaging, a label insert, containers present in the kits, and the like
The following examples are offered by way of illustration and not by way of limitation EXPERIMENTAL A Preparation of Ketone Test Strip
An 0 8 μm nylon membrane obtained from Cuno (Meridien, CT) was dipped into the reagent of Table 1, until saturated
Table 1
The excess reagent was scraped off gently with a glass rod The resulting membrane was hung to dry in a 56 °C oven for 10 minutes Porex (0 6 mm thick) was soaked in the 5% nitrite solution and then hung to dry in a 100 °C oven for ten hours Finally, the membrane was laminated between a polyester stock (0 4 mm Melenex® polyester from ICI America, Wilmington DE) and the nitrite impregnated Porex
B Assays
Using the following protocol, 10 μL of aqueous samples comprising 40mg/dL (D) β- hydroxybutyrate were tested on strips as described above, where the strips varied in terms of the amount of PMS and/or Diaphorase present on the strip A 10 ml aqueous sample was applied onto a freshly prepared test strip The strip was inserted into a reflectometer and data acquisition was commenced The relectance of the reading strip was monitored at 660 nm at one-second intervals for two minutes Next, the data were uploaded from the reflectometer's memory buffer to a personal computer via a modified serial cable The reaction rate was calculated based on the initial rate of change in K/S at the range where the reaction profile was linear The results summarized in Table 2 were averages of five replicates . In each individual assay, the reaction rate (in terms of K/S per sec) was observed (K/S is a measure of reflectance, discussed and defined in USP 4,935,346, col 14, the disclosure of which is herein incorporated by reference ) Table 2 provides the results
Table 2
f Theoretical rate, i e the predicted rate based on the sum of the reaction rate catalyzed by diaphorase and PMS individually
* The reaction is too fast and difficult to calculate the rate precisely
C Observed Rate v Theoretical Rate
Table 3 below provides a comparison of the observed rate and the expected or theoretical rate for the above described assays.
Table 3
Fig 1 provides a graph of the observed rate vs the theoretical rate As can be seen by the graph of Figure 1, the reaction rate of the signal producing system of the test strip is accelerated by the presence of both PMS and Diaphorase, where the magnitude of the observed acceleration is unexpectedly greater than the predicted amount of acceleration based on the sum of the reaction rates of systems having PMS or Diaphorase individually
It is evident from the above results and discussion that the subject invention provides for a significant and unexpected enhancement in the rate of reaction observed in an analyte detection protocol based on the oxidation of an analyte and the concomitant reduction of a redox indicator In addition, the subject invention provides for a more economical manner of analyte detection, as compared to certain prior art methods, e g ones that rely solely on diaphorase as the electron transfer agent. As such, the subject invention represents a significant contribution to the art.
All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

Claims

WHAT IS CLAIMED IS
1 A signal producing system for detecting the presence of a reduced cofactor in a sample, said system comprising first and second electron transfer agents capable of oxidizing a reduced cofactor, and a redox indicator
2 The signal producing system according to Claim 1 , wherein said first electron transfer agent is a low molecular weight electron transfer agent
3 The signal producing system according to Claim 2, wherein said low molecular weight electron transfer agent is a phenazine compound
4 The signal producing system according to Claim 1, wherein said second electron transfer agent is a high molecular weight electron transfer agent
5 The signal producing system according to Claim 1, wherein said high molecular weight electron transfer agent is a proteinaceous compound
6 The signal producing system according to Claim 5, wherein said proteinaceous compound is an enzyme
7 The signal producing system according to Claim 1, wherein said redox indicator is a tetrazolium compound
8 The signal producing system according to Claim 1, wherein said signal producing system further comprises an enzyme cofactor
9 The signal producing system according to Claim 1, wherein said system further comprises an analyte oxidizing enzyme
10 The signal producing system according to Claim 1, wherein said signal producing system is present as a reagent composition 11 A reagent composition for use in detecting the presence of an analyte in a sample, said composition comprising an analyte oxidizing enzyme, an enzyme cofactor, a non-proteinaceous electron transfer agent, a proteinaceous electron transfer agent, and a redox indicator
12 The reagent composition according to Claim 11, wherein said enzyme cofactor is NAD(P)+
13 The reagent composition according to Claim 11, wherein said non-proteinaceous electron transfer agent is a phenazine compound
14 The reagent composition according to Claim 1 1, wherein said proteinaceous electron transfer agent is a diaphorase
15 The reagent composition according to Claim 11, wherein said redox indicator is a tetrazolium compound
16 The reagent composition according to Claim 1 1, wherein said composition is a dry reagent composition
17 A reagent composition for use in detecting the presence of an analyte in a sample, said composition comprising an analyte dehydrogenase NAD(P)+, a phenazine compound, a diaphorase, and a tetrazolium compound
18 The reagent composition according to Claim 17, wherein said phenazine compound is phenazine methosulfate 19 The reagent composition according to Claim 17, wherein said composition is a dry reagent composition
20 The reagent composition according to Claim 19, wherein said dry reagent composition is present on a test strip
21 A reagent test strip comprising
(a) a support element, and
(b) a dry reagent composition comprising (i) an analyte oxidizing enzyme,
(ii) an enzyme cofactor,
(iii) a non-proteinaceous electron transfer agent,
(iv) a proteinaceous electron transfer agent, and
(v) a redox indicator
22 The reagent test strip according to Claim 21, wherein said first enzyme is a dehydrogenase
23 The reagent test strip according to Claim 21, wherein said cofactor is NAD(P)+
24 The reagent test strip according to Claim 21, wherein said non-proteinaceous electron transfer agent is a phenazine compound
25 The reagent test strip according to Claim 24, wherein said phenazine compound is phenazine methosulfate
26 The reagent test strip according to Claim 21, wherein said proteinaceous electron transfer agent is a diaphorase
27 The reagent test stπp according to Claim 21, wherein said redox indicator is a tetrazolium compound 28 In a method for detecting the presence of an analyte in a sample, the improvement comprising employing a signal producing system according to Claim 1
29 The method according to Claim 28, wherein said signal producing system is present as a reagent composition according to Claim 11
30 The method according to Claim 29, wherein said reagent composition is present on a reagent test strip according to Claim 21
31 A kit for use in detecting the presence of an analyte in a sample, said kit comprising a signal producing system according to Claim 1
32 The kit according to Claim 31, wherein said signal producing system is present as a reagent composition according to Claim 11
33 The kit according to Claim 32, wherein said reagent composition is present on a reagent test strip according to Claim 21
34 The kit according to Claim 31 , wherein said kit further comprises a means for obtaining a physiological sample
35 The kit according to Claim 34, wherein said means for obtaining a physiological sample is a lance
EP01916527A 2000-03-28 2001-03-08 Reagents and methods for detecting a reduced cofactor Withdrawn EP1268849A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53720300A 2000-03-28 2000-03-28
US537203 2000-03-28
PCT/US2001/007619 WO2001073114A2 (en) 2000-03-28 2001-03-08 Reagents and methods for detecting a reduced cofactor

Publications (1)

Publication Number Publication Date
EP1268849A2 true EP1268849A2 (en) 2003-01-02

Family

ID=24141653

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01916527A Withdrawn EP1268849A2 (en) 2000-03-28 2001-03-08 Reagents and methods for detecting a reduced cofactor

Country Status (13)

Country Link
EP (1) EP1268849A2 (en)
JP (1) JP2003528623A (en)
KR (1) KR20020089412A (en)
CN (1) CN1419604A (en)
AR (1) AR027726A1 (en)
AU (1) AU2001243542A1 (en)
CA (1) CA2404421A1 (en)
HK (1) HK1050030A1 (en)
IL (1) IL151262A0 (en)
MX (1) MXPA02009469A (en)
PL (1) PL357180A1 (en)
RU (1) RU2266543C2 (en)
WO (1) WO2001073114A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
GB0204232D0 (en) * 2002-02-22 2002-04-10 Isis Innovation Assay
TR201810169T4 (en) 2003-06-20 2018-08-27 Hoffmann La Roche Method and marker for producing narrow, homogeneous marker strips.
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7604721B2 (en) 2003-06-20 2009-10-20 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US7597793B2 (en) 2003-06-20 2009-10-06 Roche Operations Ltd. System and method for analyte measurement employing maximum dosing time delay
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US7556723B2 (en) 2004-06-18 2009-07-07 Roche Diagnostics Operations, Inc. Electrode design for biosensor
ITMI20050881A1 (en) * 2005-05-16 2006-11-17 Anna Favre DIAGNOSTIC KIT FOR HIRSCHSPRUNG MEGALON CONGENITAL DISEASE
DE102006002165A1 (en) * 2006-01-17 2007-07-19 Merck Patent Gmbh Determining acetate content in a sample, comprises contacting a sample with test strip comprising e.g. tetrazolium salt, incubating the test strip, contacting test strip with phenazine methosulfate reagent and observing color change
WO2011107238A1 (en) * 2010-03-01 2011-09-09 System Biologie Ag Test strip for the detection of equol
CN102520198A (en) * 2011-11-21 2012-06-27 宁波美康生物科技股份有限公司 Ethanol concentration detection kit and manufacture method thereof
CN102520150A (en) * 2011-12-08 2012-06-27 上海高丰医疗电器有限公司 Diagnostic test paper for determination of gamma-hydroxybutanoic acid and preparation method thereof
US8921061B2 (en) 2012-11-02 2014-12-30 Roche Diagnostics Operations, Inc. Reagent materials and associated test elements
US8920628B2 (en) 2012-11-02 2014-12-30 Roche Diagnostics Operations, Inc. Systems and methods for multiple analyte analysis
CN107533028A (en) * 2015-05-07 2018-01-02 聚合物技术系统公司 Systems and methods for electrochemical ketone detection and measurement
CN108359710B (en) * 2018-02-11 2019-04-30 山东大学齐鲁医院 Enzyme chromogenic quantitative assay kit and assay method for glucose phosphate isomerase
CN110117791B (en) * 2019-05-23 2023-11-10 电子科技大学 Binding force promoter for brown oxide liquid of high-density interconnection printed circuit board

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247894A1 (en) * 1982-12-24 1984-06-28 Merck Patent Gmbh, 6100 Darmstadt TEST SYSTEM AND METHOD FOR DETERMINING NAD (P) H
JPS60180600A (en) * 1984-02-29 1985-09-14 Kyowa Medetsukusu Kk Determination of reduced-type nicotinamide adenine dinucleotide
US5036000A (en) * 1986-12-16 1991-07-30 Enzymatics, Inc. Threshold color control system
SE466158B (en) * 1989-04-25 1992-01-07 Migrata Uk Ltd METHOD OF ANALYSIS FOR GLUCOSE DETERMINATION IN WHOLE BLOOD
DE4311464A1 (en) * 1993-04-08 1994-10-13 Boehringer Mannheim Gmbh Method for the colorimetric determination of an analyte with a PQQ-dependent dehydrogenase
US5902731A (en) * 1998-09-28 1999-05-11 Lifescan, Inc. Diagnostics based on tetrazolium compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO0173114A3 *

Also Published As

Publication number Publication date
RU2266543C2 (en) 2005-12-20
RU2002123839A (en) 2004-03-10
JP2003528623A (en) 2003-09-30
CN1419604A (en) 2003-05-21
WO2001073114A3 (en) 2002-03-28
MXPA02009469A (en) 2003-02-24
KR20020089412A (en) 2002-11-29
IL151262A0 (en) 2003-04-10
CA2404421A1 (en) 2001-10-04
HK1050030A1 (en) 2003-06-06
PL357180A1 (en) 2004-07-26
WO2001073114A2 (en) 2001-10-04
AR027726A1 (en) 2003-04-09
AU2001243542A1 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
US6586199B2 (en) Stabilized tetrazolium reagent compositions and methods for using the same
EP1317563B1 (en) Test-strips with positively charged membranes for tetrazolium based assays
TW558638B (en) Diagnostic based on tetrazolium compounds
WO2001073114A2 (en) Reagents and methods for detecting a reduced cofactor
EP1312921A1 (en) Stabilized tetrazolium-phenazine reagent compositions and methods for using the same
AU2003207797A1 (en) Method and test strips for the measurement of fat loss during weight loss programs
HK1053856B (en) Test-strips with positively charged membranes for tetrazolium based assays
AU2001288935A2 (en) Test-strips with positively charged membranes for tetrazolium based assays
HK1026001B (en) Diagnostics based on tetrazolium compounds
HK1025604A (en) Diagnostics based on tetrazolium compounds
HK1025604B (en) Diagnostics based on tetrazolium compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20050207

17Q First examination report despatched

Effective date: 20050207

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070411

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1050030

Country of ref document: HK